NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells

Journal of Immunology

Volumn 164, Issue 4, 2000, Pages 2009-2015

  Slifka, Mark K ^a   Pagarigan, Robb R ^a   Whitton, J Lindsay ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL SURFACE MARKER; GANGLIOTETRAOSYLCERAMIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; HOST RESISTANCE; LYMPHOCYTE DEPLETION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS IMMUNITY; VIRUS INFECTION;

EID: 0034652037     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.4.2009     Document Type: Article

References (41)

1. Welsh, R. M., and R. M. Zinkernagel. 1977. Heterospecific cytotoxic cell activity induced during the first three days of acute lymphocytic choriomeningitis virus infection in mice. Nature 268:646.
2. Kiessling, R., E. Eriksson, L. A. Hallenbeck, and R. M. Welsh. 1980. A comparative analysis of the cell surface properties of activated vs. endogenous mouse natural killer cells. J. Immunol. 125:1551.
3. Biron, C. A. 1997. Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9:24.
4. Lanier, L. L. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359.
5. Biron, C. A., and R. T. Gazzinelli. 1995. Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. Curr. Opin. Immunol. 7:485.
6. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320:1731.
7. + T cells as novel interleukin-12-responsive killer T cell precursors. Jpn. J. Cancer Res. 87:429.
8. Parker, S. E., Y. H. Sun, and D. W. Sears. 1988. Differential expression of the ASGM1 antigen on anti-reovirus and alloreactive cytotoxic T lymphocytes (CTL). J. Immunogenet. 15:215.
9. Doherty, P. C., and J. E. Allan. 1987. Anti-asialo GM-1 eliminates both inflammatory process and cytotoxic T-cell function in the lymphocytic choriomeningitis adoptive transfer model. Cell. Immunol. 107:1.
10. Stitz, L., J. Baenziger, H. Pircher, H. Hengartner, and R. M. Zinkernagel. 1986. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities. J. Immunol. 136:4674.
11. Charley, M. R., A. Mikhael, J. Hackett, V. Kumar, and M. Bennett. 1988. Mechanism of anti-asialo GM1 prevention of graft-vs-host disease: identification of allo-antigen activated T cells. J. Invest. Dermatol. 91:202.
12. Kasai, M., M. Iwamori, Y. Nagai, K. Okumura, and T. Tada. 1980. A glycolipid on the surface of mouse natural killer cells. Eur. J. Immunol. 10:175.
13. + T cells. Curr. Opin. Immunol. 7:367.
14. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278:1623.
15. + T cell populations. Int. Immunol. 7:1157.
16. - T cells in mice and humans. J. Exp. Med. 180:1097.
17. Yanagi, Y., A. Tishon, H. Lewicki, B. A. Cubitt, and M. B. A. Oldstone. 1992. Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule. J. Virol. 66:2527.
18. Lin, M. Y., and R. M. Welsh. 1998. Stability and diversity of T cell receptor repertoire usage during lymphocytic choriomeningitis virus infection of mice. J. Exp. Med. 188:1993.
19. Sourdive, D. J., K. Murali-Krishna, J. D. Altman, A. J. Zajac, J. K. Whitmire, C. Pannetier, P. Kourilsky, B. Evavold, A. Sette, and R. Ahmed. 1998. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J. Exp. Med. 188:71.
20. + cells. J. Immunol. 160:1158.
21. von Herrath, M. G., B. Coon, H. Lewicki, H. Mazarguil, J. E. Gairin, and M. B. A. Oldstone. 1998. In vivo treatment with a MHC class I-restricled blocking peptide can prevent virus-induced autoimmune diabetes. J. Immunol. 161: 5087.
22. Burkhart, C., G. Freer, R. Castro, L. Adorini, K. H. Wiesmuller, R. M. Zinkernagel, and H. Hengartner. 1994. Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus. J. Virol. 68:1573.
23. Whitton, J. L., and A. Tishon. 1990. Use of CTL clones in vitro to map CTL epitopes. In Animal Virus Pathogenesis: A Practical Approach. M. B. A. Oldstone, ed. Oxford University Press, Oxford, p. 104.
24. Byrne, J. A., and M. B. A. Oldstone. 1984. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J. Virol. 51:682.
25. + T lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J. Virol. 61:1867.
26. Whitton, J. L. 1990. Lymphocytic choriomeningitis virus CTL. Sem. Virol. 1:257.
27. Fung-Leung, W. P., T. M. Kundig, R. M. Zinkernagel, and T. W. Mak. 1991. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression. J. Exp. Med. 174:1425.
28. Walsh, C. M., M. Matloubian, C. C. Liu, R. Ueda, C. G. Kurahara, J. L. Christensen, M. T. Huang, J. D. Young, R. Ahmed, and W. R. Clark. 1994. Immune function in mice lacking the perform gene. Proc. Natl. Acad. Sci. USA 91:10854.
29. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
30. Shen, H., M. K. Slifka, M. Matloubian, E. R. Jensen, R. Ahmed, and I. F. Miller. 1995. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc. Natl. Acad. Sci. USA 92:3987.
31. + T cells during an acute virus infection. Immunity 8:167.
32. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177.
33. + T cells. Nature 401:76.
34. + T cells during acute infection with lymphocytic choriomeningitis virus. J. Immunol. 161:3215.
35. Whitmire, J. K., M. S. Asano, K. Murali-Krishna, M. Suresh, and R. Ahmed. 1998. Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection. J. Virol. 72:8281.
36. Ehl, S., R. Nuesch, T. Tanaka, M. Myasaka, H. Hengartner, and R. M. Zinkernagel. 1996. A comparison of efficacy and specificity of three NK depleting antibodies. J. Immunol. Methods 199:149.
37. Sprent, J., X. Zhang, S. Sun, and D. Tough. 1999. T-cell turnover in vivo and the role of cytokines. Immunol. Lett. 65:21.
38. Budd, R. C., G. C. Miescher, R. C. Howe, R. K. Lees, C. Bron, and H. R. Macdonald. 1987. Developmentally regulated expression of T cell receptor β chain variable domains in immature thymocytes. J. Exp. Med. 166:577.
39. Fowlkes, B. J., A. M. Kruisbeek, H. Ton-That, M. A. Weston, J. E. Coligan, R. H. Schwartz, and D M. Pardoll. 1987. A novel population of T-cell receptor αβ-bearing thymocytes which predominantly expresses a single Vβ gene family. Nature 329:251.
40. Cui, J., N. Watanabe, T. Kawano, M. Yamashita, T. Kamata, C. Shimizu, M. Kimura, E. Shimizu, J. Koike, H. Koseki, Y. Tanaka, M. Taniguchi, and T. Nakayama. 1999. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer T cells. J. Exp. Med. 190:783.
41. Mingari, M. C., A. Moretta, and L. Moretta. 1998. Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. Immunol. Today 19:153.